Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D

The Alphabet spinoff SandboxAQ has signed up AstraZeneca and Sanofi as users of its drug discovery and development tools. Fresh from raising $500 million, the startup has secured the big-name customers for a newly established biopharma molecular simulation division that aims to accelerate R&D.